Publication

Byline

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... और पढ़ें


Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... और पढ़ें


Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effic... और पढ़ें


Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascend... और पढ़ें


Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant ... और पढ़ें


Lords Mark Industries wins order from CREDA, Govt. of Chhattisgarh

Mumbai, July 20 -- Lords Mark Industries announced that its receives an order from Chhattisgarh State Renewable Energy Development Agency (CREDA), Department of Energy, Government of Chhattisgarh for ... और पढ़ें


Tips Music soars as board to mull share buyback on 22 July

Mumbai, July 20 -- The board will also consider and approve Q1 FY27 financial results at the same meeting. As of June 2026, the company's promoters held a 64.15% stake in Tips Music. Tips Music is e... और पढ़ें


Anwar orders review of civil service promotions after officers wait up to eight years

KAJANG, July 20 -- Prime Minister Datuk Seri Anwar Ibrahim has instructed Chief Secretary to the Government (KSN) Tan Sri Shamsul Azri Abu Bakar to review civil service promotion processes that have b... और पढ़ें


Another American soldier killed as US, Iran continue strikes

Nigeria, July 20 -- A US soldier has been killed in Iraq, bringing to 17 the number of American soldiers that have been confirmed killed in the war with Iran. The US Central Command (CENTCOM) announc... और पढ़ें


Maruti Suzuki Brezza facelift spied undisguised in base trim ahead of launch

India, July 20 -- Maruti Suzuki is preparing a mid-life update for the Brezza, and the SUV has now been seen undisguised in base LXI trim ahead of its scheduled launch on July 23. The latest sighting ... और पढ़ें